Phenazopyridine in the management of autonomic dysreflexia associated with urinary tract infection

Journal of Spinal Cord Medicine

Volumn 26, Issue 4, 2003, Pages 409-411

  Paola, Frederick Adolf ^a   Sales, Donna ^b   Garcia Zozaya, Iñigo ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autonomic dysreflexia; Cystitis; Phenazopyridine; Spinal cord injuries; Tetraplegia; Urinary tract infection

Indexed keywords

ASCORBIC ACID; BACLOFEN; COTRIMOXAZOLE; DIAZEPAM; GLYCERYL TRINITRATE; LEVOFLOXACIN; METHENAMINE HIPPURATE; PHENAZOPYRIDINE;

ADULT; ARTICLE; AUTONOMIC DYSREFLEXIA; CASE REPORT; CHILL; CLINICAL FEATURE; CYSTITIS; DIAPHORESIS; DISEASE ASSOCIATION; DRUG EFFICACY; FLUSHING; HEADACHE; HEMATURIA; HUMAN; HYPERTENSION; MALE; QUADRIPLEGIA; RECURRENT INFECTION; SPASTICITY; SYMPTOM; UNITED STATES; URINARY TRACT INFECTION;

EID: 0348109358     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2003.11753714     Document Type: Article

References (17)

1. Campagnolo DI, Merli GJ. Autonomic and cardiovascular complications of spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA, eds. Spinal Cord Medicine. Philadelphia, Pa: Lippincott Williams and Wilkins; 2002:123-134.
2. Hammond MC, ed. Medical Care of Persons With Spinal Cord Injury. Dept of Veterans Affairs Employee Education System; Washington, DC, US Government Printing Office, 1998.
3. Moeller BA Jr, Scheinberg D. Autonomic dysreflexia in injuries below the sixth thoracic segment. JAMA. 1973;224:1295.
4. Gimovsky ML, Ojeda A, Ozaki R, Zerne S. Management of autonomic hyperreflexia associated with a low thoracic spinal cord lesion. Am J Obstet Gynecol. 1985;153:223-224.
5. McEvoy GK, ed. Drug Information AHFS. 2002. Bethesda, Md: American Society for Health System Pharmacists; 2002:3448.
6. American Spinal Injuries Association. International Standards for Neurological Classification of Spinal Injury. J Spinal Cord Med. 2003;26(suppl 1):s50-s56
7. Consortium for Spinal Cord Medicine. Acute Management of Autonomic Dysreflexia: Adults With Spinal Cord Injury Presenting to Health-Care Facilities. Washington, DC: Paralyzed Veterans of America; 2001.
8. Ozawa H, Jung SY, Fraser MO, Rivas DA, Chancellor MB. Intravesical capsaicin therapy: a review. J Spinal Cord Med. 1999;22:114-118.
9. Amit G, Halkin A. Lemon-yellow nails and long-term phenazopyridine use. Ann Intern Med. 1997;127:1137.
10. Landman J, Kavaler E, Waterhouse RL Jr. Acquired methemoglobinemia possibly related to phenazopyridine in a woman with normal renal function. J Urol. 1997;158:1520-1521.
11. Herlihy TE. Phenazopyridine and aseptic meningitis. Ann Intern Med. 1987;106:172-173.
12. Rule KA, Biggs AW. Transient renal failure following phenazopyridine overdose. Urology. 1984;24:178-179.
13. Thomas RJ, Doddabele S, Karnad AB. Chronic severe hemolytic anemia related to surrepetitious phenazopyridine abuse. Ann Intern Med. 1994;121:308.
14. Badley BW. Phenazopyridine-induced hepatitis. BMJ. 1976;2:850.
15. Goldfinger SE, Marx S. Hypersensitivity hepatitis due to phenazopyridine hydrochloride. N Engl J Med. 1972;286:1090-1091.
16. Crawford ED, Mulvaney WP. Rapid increase in calculous size: a possible hazard of phenazopyridine hydrochloride therapy in the presence of already formed stones. J Urol. 1978;119:280-281.
17. Mulvaney WP, Beck CW, Brown RR. Urinary phenazopyridine stones. A complication of therapy. JAMA. 1972;221:1511-1512.